CDCA5 Human 1,1-dichloroethene increases expression ISO Cdca5 (Mus musculus) 6480464 vinylidene chloride results in increased expression of CDCA5 mRNA CTD PMID:26682919 CDCA5 Human 1,2-dimethylhydrazine increases expression ISO Cdca5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of CDCA5 mRNA CTD PMID:22206623 CDCA5 Human 17alpha-ethynylestradiol affects expression ISO Cdca5 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of CDCA5 mRNA CTD PMID:17555576 CDCA5 Human 17alpha-ethynylestradiol multiple interactions ISO Cdca5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDCA5 mRNA CTD PMID:17942748 CDCA5 Human 17alpha-ethynylestradiol increases expression ISO Cdca5 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of CDCA5 mRNA CTD PMID:17942748 CDCA5 Human 17beta-estradiol increases expression ISO Cdca5 (Mus musculus) 6480464 Estradiol results in increased expression of CDCA5 mRNA CTD PMID:25210133 CDCA5 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CDCA5 mRNA CTD PMID:19167446 and PMID:20106945 CDCA5 Human 17beta-estradiol multiple interactions ISO Cdca5 (Mus musculus) 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of CDCA5 mRNA] CTD PMID:25210133 CDCA5 Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Cdca5 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 CDCA5 Human 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Cdca5 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 CDCA5 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CDCA5 mRNA CTD PMID:19684285 CDCA5 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cdca5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CDCA5 mRNA CTD PMID:21570461 and PMID:23994337 CDCA5 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CDCA5 mRNA CTD PMID:22574217 CDCA5 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cdca5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CDCA5 mRNA CTD PMID:15328365 more ... CDCA5 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of CDCA5 mRNA CTD PMID:19684285 CDCA5 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cdca5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDCA5 mRNA CTD PMID:17942748 CDCA5 Human 2-palmitoylglycerol increases expression EXP 6480464 2-palmitoylglycerol results in increased expression of CDCA5 mRNA CTD PMID:37199045 CDCA5 Human 3,3',4,4',5-pentachlorobiphenyl affects expression ISO Cdca5 (Mus musculus) 6480464 3 more ... CTD PMID:23994337 CDCA5 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDCA5 mRNA CTD PMID:28628672 CDCA5 Human 3-methylcholanthrene increases expression ISO Cdca5 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of CDCA5 mRNA CTD PMID:20713471 CDCA5 Human 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of CDCA5 mRNA CTD PMID:16709241 CDCA5 Human acetamide increases expression ISO Cdca5 (Rattus norvegicus) 6480464 acetamide results in increased expression of CDCA5 mRNA CTD PMID:31881176 CDCA5 Human acrylamide increases expression ISO Cdca5 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of CDCA5 mRNA CTD PMID:28959563 CDCA5 Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of CDCA5 protein CTD PMID:20106945 CDCA5 Human aflatoxin B1 increases expression ISO Cdca5 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of CDCA5 mRNA CTD PMID:19770486 CDCA5 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of CDCA5 mRNA CTD PMID:33167477 CDCA5 Human antimycin A increases expression EXP 6480464 Antimycin A results in increased expression of CDCA5 mRNA CTD PMID:33512557 CDCA5 Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of CDCA5 mRNA CTD PMID:33212167 CDCA5 Human arsane multiple interactions ISO Cdca5 (Mus musculus) 6480464 [APOE protein affects the susceptibility to Arsenic] which affects the expression of CDCA5 mRNA CTD PMID:22719926 CDCA5 Human arsenic atom multiple interactions ISO Cdca5 (Mus musculus) 6480464 [APOE protein affects the susceptibility to Arsenic] which affects the expression of CDCA5 mRNA CTD PMID:22719926 CDCA5 Human arsenite(3-) multiple interactions EXP 6480464 arsenite inhibits the reaction [G3BP1 protein binds to CDCA5 mRNA] CTD PMID:32406909 CDCA5 Human azathioprine decreases expression EXP 6480464 Azathioprine results in decreased expression of CDCA5 mRNA CTD PMID:22623647 CDCA5 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CDCA5 mRNA CTD PMID:20064835 CDCA5 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CDCA5 mRNA CTD PMID:32234424 CDCA5 Human benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of CDCA5 3' UTR CTD PMID:27901495 CDCA5 Human benzo[a]pyrene increases expression ISO Cdca5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CDCA5 mRNA CTD PMID:20504355 more ... CDCA5 Human benzo[a]pyrene decreases expression ISO Cdca5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CDCA5 mRNA CTD PMID:19770486 CDCA5 Human benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:19150397 CDCA5 Human benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:20382639 CDCA5 Human benzo[b]fluoranthene increases expression ISO Cdca5 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of CDCA5 mRNA CTD PMID:26377693 CDCA5 Human beta-naphthoflavone affects expression ISO Cdca5 (Mus musculus) 6480464 beta-Naphthoflavone affects the expression of CDCA5 mRNA CTD PMID:23994337 CDCA5 Human bis(2-chloroethyl) sulfide decreases expression EXP 6480464 Mustard Gas results in decreased expression of CDCA5 mRNA CTD PMID:25102026 CDCA5 Human bisphenol A affects expression ISO Cdca5 (Rattus norvegicus) 6480464 bisphenol A affects the expression of CDCA5 mRNA CTD PMID:25181051 CDCA5 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CDCA5 mRNA CTD PMID:30903817 CDCA5 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CDCA5 mRNA CTD PMID:29275510 CDCA5 Human bisphenol A multiple interactions EXP 6480464 [[ginger extract results in increased abundance of Oils more ... CTD PMID:28628672 and PMID:33376534 CDCA5 Human cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of CDCA5 mRNA CTD PMID:21120746 CDCA5 Human caffeine decreases phosphorylation EXP 6480464 Caffeine results in decreased phosphorylation of CDCA5 protein CTD PMID:35688186 CDCA5 Human calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of CDCA5 mRNA CTD PMID:21592394 CDCA5 Human calcitriol multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA5 mRNA CTD PMID:21592394 CDCA5 Human cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of CDCA5 mRNA CTD PMID:36519830 CDCA5 Human carbon nanotube affects expression ISO Cdca5 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of CDCA5 mRNA CTD PMID:25554681 CDCA5 Human carbon nanotube increases expression ISO Cdca5 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of CDCA5 mRNA CTD PMID:25554681 CDCA5 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to CDCA5 gene] CTD PMID:28238834 CDCA5 Human choline multiple interactions ISO Cdca5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDCA5 mRNA CTD PMID:20938992 CDCA5 Human chromium(6+) multiple interactions EXP 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CDCA5 mRNA CTD PMID:38479592 CDCA5 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of CDCA5 mRNA CTD PMID:27594783 CDCA5 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CDCA5 mRNA CTD PMID:27392435 CDCA5 Human copper atom increases expression ISO Cdca5 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of CDCA5 mRNA CTD PMID:26033743 CDCA5 Human copper(0) increases expression ISO Cdca5 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of CDCA5 mRNA CTD PMID:26033743 CDCA5 Human coumarin affects phosphorylation EXP 6480464 coumarin affects the phosphorylation of CDCA5 protein CTD PMID:35688186 CDCA5 Human coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 CDCA5 Human coumestrol increases expression EXP 6480464 Coumestrol results in increased expression of CDCA5 mRNA CTD PMID:19167446 CDCA5 Human cycloheximide increases expression EXP 6480464 Cycloheximide results in increased expression of CDCA5 mRNA CTD PMID:19684285 CDCA5 Human cycloheximide multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of CDCA5 mRNA CTD PMID:19684285 CDCA5 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CDCA5 mRNA CTD PMID:20106945 more ... CDCA5 Human DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CDCA5 mRNA CTD PMID:38568856 CDCA5 Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDCA5 mRNA CTD PMID:28628672 CDCA5 Human diazinon affects expression ISO Cdca5 (Rattus norvegicus) 6480464 Diazinon affects the expression of CDCA5 mRNA CTD PMID:22546817 CDCA5 Human dibenz[a,h]anthracene increases expression ISO Cdca5 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 CDCA5 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of CDCA5 mRNA CTD PMID:37042841 CDCA5 Human dibutyl phthalate decreases expression ISO Cdca5 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of CDCA5 mRNA CTD PMID:17361019 and PMID:21266533 CDCA5 Human dibutyl phthalate multiple interactions EXP 6480464 N-methyl-delta-3 more ... CTD PMID:36828243 CDCA5 Human dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CDCA5 mRNA CTD PMID:36828243 CDCA5 Human diclofenac increases expression ISO Cdca5 (Mus musculus) 6480464 Diclofenac results in increased expression of CDCA5 mRNA CTD PMID:26934552 CDCA5 Human dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of CDCA5 mRNA CTD PMID:26516004 CDCA5 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CDCA5 mRNA CTD PMID:30031762 CDCA5 Human endosulfan increases expression ISO Cdca5 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of CDCA5 mRNA CTD PMID:29391264 CDCA5 Human Enterolactone multiple interactions EXP 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA5 mRNA CTD PMID:19167446 CDCA5 Human folic acid multiple interactions ISO Cdca5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDCA5 mRNA CTD PMID:20938992 CDCA5 Human FR900359 affects phosphorylation EXP 6480464 FR900359 affects the phosphorylation of CDCA5 protein CTD PMID:37730182 CDCA5 Human genistein affects expression EXP 6480464 Genistein affects the expression of CDCA5 mRNA CTD PMID:18847459 CDCA5 Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDCA5 mRNA CTD PMID:28628672 CDCA5 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of CDCA5 protein CTD PMID:32959892 CDCA5 Human L-methionine multiple interactions ISO Cdca5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDCA5 mRNA CTD PMID:20938992 CDCA5 Human leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of CDCA5 mRNA CTD PMID:28988120 CDCA5 Human menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of CDCA5 mRNA CTD PMID:20044591 CDCA5 Human methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of CDCA5 mRNA CTD PMID:23649840 CDCA5 Human N-nitrosodiethylamine multiple interactions ISO Cdca5 (Mus musculus) 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDCA5 mRNA] CTD PMID:17854601 CDCA5 Human N-nitrosodiethylamine increases expression ISO Cdca5 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CDCA5 mRNA CTD PMID:17854601 CDCA5 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of CDCA5 mRNA CTD PMID:25583101 CDCA5 Human nickel dichloride affects expression ISO Cdca5 (Rattus norvegicus) 6480464 nickel chloride affects the expression of CDCA5 mRNA CTD PMID:22546817 CDCA5 Human niclosamide decreases expression EXP 6480464 Niclosamide results in decreased expression of CDCA5 mRNA CTD PMID:28284560 CDCA5 Human ozone multiple interactions ISO Cdca5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CDCA5 mRNA more ... CTD PMID:25658374 more ... CDCA5 Human ozone increases expression ISO Cdca5 (Mus musculus) 6480464 Ozone results in increased expression of CDCA5 mRNA CTD PMID:33026818 CDCA5 Human palbociclib decreases expression EXP 6480464 palbociclib results in decreased expression of CDCA5 mRNA CTD PMID:22869556 CDCA5 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CDCA5 mRNA CTD PMID:22230336 CDCA5 Human paracetamol increases expression ISO Cdca5 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of CDCA5 mRNA CTD PMID:33387578 CDCA5 Human PCB138 multiple interactions ISO Cdca5 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 CDCA5 Human perfluorooctanoic acid multiple interactions EXP 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of CDCA5 mRNA CTD PMID:33325755 CDCA5 Human perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CDCA5 mRNA CTD PMID:36326898 CDCA5 Human phenobarbital affects expression ISO Cdca5 (Mus musculus) 6480464 Phenobarbital affects the expression of CDCA5 mRNA CTD PMID:23091169 CDCA5 Human phenobarbital increases expression ISO Cdca5 (Mus musculus) 6480464 Phenobarbital results in increased expression of CDCA5 mRNA CTD PMID:20403969 and PMID:23091169 CDCA5 Human phytoestrogen multiple interactions EXP 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of CDCA5 mRNA CTD PMID:33325755 CDCA5 Human pirinixic acid multiple interactions ISO Cdca5 (Mus musculus) 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of CDCA5 mRNA] CTD PMID:17950772 CDCA5 Human pirinixic acid increases expression ISO Cdca5 (Mus musculus) 6480464 pirinixic acid results in increased expression of CDCA5 mRNA CTD PMID:17950772 and PMID:23811191 CDCA5 Human potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of CDCA5 protein CTD PMID:23718831 CDCA5 Human propanal decreases expression EXP 6480464 propionaldehyde results in decreased expression of CDCA5 mRNA CTD PMID:26079696 CDCA5 Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of CDCA5 mRNA CTD PMID:21632981 CDCA5 Human resveratrol multiple interactions EXP 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CDCA5 mRNA CTD PMID:19167446 CDCA5 Human silicon dioxide increases expression ISO Cdca5 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of CDCA5 mRNA CTD PMID:29341224 CDCA5 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CDCA5 mRNA CTD PMID:29301061 and PMID:34032870 CDCA5 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CDCA5 mRNA CTD PMID:38568856 CDCA5 Human sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of CDCA5 mRNA CTD PMID:31533062 CDCA5 Human T-2 toxin increases expression ISO Cdca5 (Rattus norvegicus) 6480464 T-2 Toxin results in increased expression of CDCA5 mRNA CTD PMID:26141394 CDCA5 Human tacrolimus hydrate increases expression ISO Cdca5 (Mus musculus) 6480464 Tacrolimus results in increased expression of CDCA5 mRNA CTD PMID:29362864 CDCA5 Human testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of CDCA5 mRNA CTD PMID:21592394 CDCA5 Human testosterone multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA5 mRNA CTD PMID:21592394 CDCA5 Human tetrachloromethane increases expression ISO Cdca5 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CDCA5 mRNA CTD PMID:17484886 and PMID:31919559 CDCA5 Human thioacetamide increases expression ISO Cdca5 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of CDCA5 mRNA CTD PMID:34492290 CDCA5 Human titanium dioxide increases expression ISO Cdca5 (Mus musculus) 6480464 titanium dioxide results in increased expression of CDCA5 mRNA CTD PMID:23557971 CDCA5 Human titanium dioxide decreases methylation ISO Cdca5 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of CDCA5 gene CTD PMID:35295148 CDCA5 Human trichloroethene increases expression ISO Cdca5 (Mus musculus) 6480464 Trichloroethylene results in increased expression of CDCA5 mRNA CTD PMID:25549359 CDCA5 Human trimellitic anhydride increases expression ISO Cdca5 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of CDCA5 mRNA CTD PMID:19042947 CDCA5 Human troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CDCA5 mRNA CTD PMID:19140230 CDCA5 Human trovafloxacin decreases expression ISO Cdca5 (Mus musculus) 6480464 trovafloxacin results in decreased expression of CDCA5 mRNA CTD PMID:35537566 CDCA5 Human urethane increases expression EXP 6480464 Urethane results in increased expression of CDCA5 mRNA CTD PMID:28818685 CDCA5 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CDCA5 mRNA CTD PMID:19101580 CDCA5 Human valproic acid decreases expression ISO Cdca5 (Mus musculus) 6480464 Valproic Acid results in decreased expression of CDCA5 mRNA CTD PMID:21427059 CDCA5 Human zinc atom multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CDCA5 mRNA CTD PMID:18593933 CDCA5 Human zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of CDCA5 mRNA CTD PMID:22171008 CDCA5 Human zinc(0) multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CDCA5 mRNA CTD PMID:18593933 CDCA5 Human zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of CDCA5 mRNA CTD PMID:22171008 CDCA5 Human zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of CDCA5 protein CTD PMID:28871336